LAWSUITS NEWS & LEGAL INFORMATION
Search Results for
Sort by date 572 pages found matching <script>alert('What_Security?')</script>- Kugel Mesh Risk Widespread: Part 2
Jul-13-07 Washington, DC: In Part 1 of this article, I discussed the Food and Drug Administration's recall of a variety of Bard Composix Kugel Mesh patches, the patches especially designed for hernia repair surgery. I also described what happened when the "spring-loaded" memory recoil ring in the defective Kugel Mesh patches pops open: The sharp ends of the r... - MRIs: A New Risk for People with CKD and Kidney Failure
Jul-11-07 New York, NY: As if living with kidney failure and chronic kidney disease (CKD) weren't enough alone—it is now known that people suffering from kidney impairment face a dangerous problem if they undergo an MRI . It turns out that they are at risk to develop a serious illness--Nephrogenic Systemic Fibrosis or NSF—from the gadolinium used as... - How Class Action Members Receive Notice
Jul-2-07 New York, NY: LawyersandSettlements.com asked notice expert Todd Hilsee how people involved in a class action lawsuit (also called plaintiffs or members) are found and notified of settlements -- and how to ensure they get the right benefits. "It is a very careful process: lawyers must notify members of their legal rights and they also need to notify the... - Link Between Avandia and Canadian Deaths Explored
Jun-18-07 Toronto, ON Health Canada has confirmed that 19 people have died from heart related problems while they were taking Avandia. Initially, Health Canada reported that since 2000, twenty-eight people who were taking Avandia had heart attacks but it did not say at the time whether or not those people died. There is not enough information in 12 of the deat... - Remembering a Hero: Asbestos Activist Les Skramstad
Jun-12-07 Missoula, MT When Lester Lewis "Les" Skramstad died at age 70 several months ago, he left a legacy of community advocacy on behalf of asbestos victims. Skramstad died at his home in Libby, Montana, following a long battle with mesothelioma, an asbestos-related illness. Even as he struggled in his last weeks, he remained outspoken on behalf of his town... - Gadolinium linked to MRI kidney failure gets New Boxed Warning
Jun-7-07 Jacksonville, FL: On May 23, 2007 the U.S. Food and Drug Administration asked manufacturers to include a new boxed warning on the product labeling of all gadolinium-based contrast agents (used in MRI and MRA scans). Patients most at risk are those with kidney malfunction, patients just before or after liver transplantation, or patients with chronic li... - High Anxiety over Avandia Report
May-30-07 Washington, DC Even the United States Senate is getting involved in the worried reaction to the report published last Monday claiming the popular diabetes drug Avandia raises the risk and severity of heart attacks. On May 21 the New England Journal of Medicine reported that an analysis of 42 separate studies on the drug concluded that Avandia rais... - Asbestos Lawsuits keep Rolling On
May-14-07 Redondo Beach, CA Ready for some more bad news about asbestos ? Apparently, asbestos poisoning is starting to strike people down at an earlier age. Why this is happening is unclear. "An increasing number of patients suffering from asbestos-related diseases are now younger than in previous reports," reads a May 9/2007 press release from the Asbestos Dis... - Protopic Warning Linked to Cancer
Apr-30-07 Washington, DC: Since January 2006, the skin ointment Protopic has been packaged with a boxed warning label intended to alert consumers that the product carries a cancer risk. This tough warning was added at the behest of the U.S. Food and Drug Administration (FDA), in response to several cancer cases among users of the drug. The only problem is, the... - Asthma Medication could Stop You Cold
Apr-21-07 Washington, DC: Americans suffering from asthma may be worse off after taking the drug Xolair , according to a recent warning by the United States Food and Drug Administration. On February 21st 2007, the FDA recommended that Genentech Inc., the makers of Xolair, include a black box alert on the product packaging that warns of a severe, and potentially... - Zelnorm: The Benefits no longer Outweigh the Risks
Apr-20-07 East Hanover, NJ: The United States Food and Drug Administration (FDA) has announced that, at its request, Novartis Pharmaceuticals has stopped sales of Zelnorm . The action was taken after a study showed increased risk of serious side effects in people taking Zelnorm. The study, conducted by Novartis and submitted to the FDA, found that patients treat... - Black Box Warning Added To Epogen, Aranesp, and Procrit
Apr-12-07 Thousand Oaks, CA: A black box warning has been added to the labels of Epogen, Aranesp, and Procrit , a sign that the U.S. Food and Drug Administration (FDA) is concerned about the risks associated with using the anemia drugs. Doctors have also been warned that patients should be given the lowest possible dose in order to avoid blood transfusions. The... - FDA Finally Yanks Permax Off the US Market
Apr-6-07 Washington, DC: On March 29, 2007, the FDA withdrew Permax (pergolide) from the market because it increases the risk of valvular heart disease. Permax belongs to a class of drugs known as dopamine agonists that help regulate balance and movement in Parkinson's patients who suffer from a lack of dopamine. When Permax was FDA approved in 1988, Eli Lilly... - FDA Strengthens Warnings on Xolair
Mar-2-07 Seattle, WA: The U.S. Food and Drug Administration (FDA) has called for a black box warning label for Xolair after receiving reports of serious allergic reactions to the drug. The alert was given after the FDA learned of 48 instances of anaphylactic shock that occurred between June, 2003 and December, 2005. Xolair was approved by the FDA for use in 20... - Suicide Risk of Neurontin Kept Hidden for Years
Feb-27-07 Washington, DC: Neurontin , the all-time poster child for an illegally promoted off-label drug, was marketed by Warner-Lambert and its Parke-Davis division until Pfizer acquired the company in 2000. The term "off-label" means prescribing a drug for indications not listed on the label, upping the recommended dose, prescribing a drug in combination with... - No End in Sight for Fen-Phen Lawsuits
Jan-29-07 Rutherford, NJ: On December 5, 2006, five women with ages ranging from 53 to 71, who took the appetite suppressants drugs known as fen-phen in 1996 and 1997, filed lawsuits against Wyeth Pharmaceuticals after being diagnosed with a life-threatening lung disorder. These lawsuits demonstrate that the harm caused by fen-phen can surface many years after a... - Experts Predict Many Cases of Permax Heart Valve Damage
Jan-21-07 Washington, DC Nearly three years ago, HealthDay News reported that a study had confirmed previous findings that the drug, Permax , used to treat Parkinson's disease, could damage heart valves and surgery would be needed to correct the problem. The April 28, 2004, report quoted the lead researcher, Dr Richard Dewey Jr, an associate professor from the U... - Ketek Liver Warnings Too Late
Dec-16-06 Chattanooga, TN: Trisha will think twice before taking another antibiotic. Her doctor prescribed Ketek for a sinus infection and Trisha believes she is "lucky to be alive," after she only took two pills. In March 2006, Trisha (not her real name pending a lawsuit) visited a local walk-in clinic complaining of flu-like symptoms; she was concerned because,... - Paxil, Pregnancy and Birth Defects
Nov-9-06 Newfoundland, PA "My psychiatrist prescribed Paxil when I was three months pregnant," says Jaime Curtis. "I feel like it is my fault that I did this to my kid; it just breaks my heart when he can't breathe." Jaime was never told about Paxil's link to birth defects. "I had a normal pregancy, just like my other two, and Geoni was born just five days... - Bausch & Lomb Fails to Warn About Dangers of ReNu Contact Lens Solution
Nov-8-06 Greenville, SC: ReNu with MoistureLoc solution has been widely used for the storing, wetting and cleaning of soft contact lenses. But here once again, a drug company has left a product on the market, with no warning to consumers, long after it was aware that serious side effects were developing in people using the product. According to the FDA, cluste...